about
Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor.Cancer therapy disparity: unequal access to breast cancer therapeutics and drug funding in CanadaInhibition of cytochromes p450: existing and new promising therapeutic targets.Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancerComparison of Changes in the Lipid Profiles of Eastern Chinese Postmenopausal Women With Early-Stage Breast Cancer Treated With Different Aromatase Inhibitors: A Retrospective Study.
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Aromatase inhibitors: a safety comparison.
@ast
Aromatase inhibitors: a safety comparison.
@en
type
label
Aromatase inhibitors: a safety comparison.
@ast
Aromatase inhibitors: a safety comparison.
@en
prefLabel
Aromatase inhibitors: a safety comparison.
@ast
Aromatase inhibitors: a safety comparison.
@en
P2860
P356
P1476
Aromatase inhibitors: a safety comparison.
@en
P2093
Felix Hilpert
Manfred Kaufmann
P2860
P304
P356
10.1517/14740338.6.2.165
P407
P50
P577
2007-03-01T00:00:00Z